cancer drugs

The FDA told Amgen to test whether a quarter-dose of sotorasib worked as well as the amount on the label. It did, but the biotech is sticking to the higher dose, which earns it an extra $180,000 a year per patient.

A Tampa-area mom couldn't watch her 9-year-old's leukemia go untreated. She started campaigning to fix a broken system and get patients the treatments they need in the face of drug shortages.

A quality-control crisis at an Indian pharmaceutical factory has left doctors and their patients with impossible choices as cheap, effective, generic cancer drugs go out of stock.

The recent, abrupt shortage of critical cancer drugs is forcing doctors to ration essential medications. It highlights a broken business model in generic drugs.

Pfizer plans to let the biotech drug developer continue innovating, except with more resources. Seagen's key products use monoclonal antibodies that help deliver a cancer-killing drug while sparing surrounding tissue.

An experimental vaccine could be on the market for ovarian-cancer patients as soon as 2022, according to the Jacksonville-based company that makes it....

The generic form of the blockbuster cancer drug is being shipped to pharmacies. The generic is likely to cost 30 percent less than the brand-name version, but Gleevec's price doubled in recent years.

Cancer patients shopping on federal and state insurance marketplaces often find it difficult to determine whether their drugs are covered and how much…

Many cancer treatments have a dark side — they can damage the heart. New research suggests this risk might be lowered in women with breast tumors if they…